1 Study Coverage 1.1 Interferon Alfa (INN) Product Introduction 1.2 Market by Type 1.2.1 Global Interferon Alfa (INN) Market Size Growth Rate by Type 1.2.2 Long-lasting Type 1.2.3 Ordinary Type 1.3 Market by Application 1.3.1 Global Interferon Alfa (INN) Market Size Growth Rate by Application 1.3.2 Hepatitis 1.3.3 Multiple Sclerosis 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Interferon Alfa (INN) Market Size, Estimates and Forecasts 2.1.1 Global Interferon Alfa (INN) Revenue 2016-2027 2.1.2 Global Interferon Alfa (INN) Sales 2016-2027 2.2 Global Interferon Alfa (INN), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Interferon Alfa (INN) Historical Market Size by Region (2016-2021) 2.3.1 Global Interferon Alfa (INN) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Interferon Alfa (INN) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Interferon Alfa (INN) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Interferon Alfa (INN) Sales Forecast by Region (2022-2027) 2.4.2 Global Interferon Alfa (INN) Revenue Forecast by Region (2022-2027) 3 Global Interferon Alfa (INN) Competitor Landscape by Players 3.1 Global Top Interferon Alfa (INN) Manufacturers by Sales 3.1.1 Global Interferon Alfa (INN) Sales by Manufacturer (2016-2021) 3.1.2 Global Interferon Alfa (INN) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Interferon Alfa (INN) Manufacturers by Revenue 3.2.1 Key Interferon Alfa (INN) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Interferon Alfa (INN) Revenue by Manufacturers (2016-2021) 3.2.3 Global Interferon Alfa (INN) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Interferon Alfa (INN) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Interferon Alfa (INN) Revenue in 2020 3.2.6 Global Interferon Alfa (INN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Interferon Alfa (INN) Price by Manufacturers 3.4 Global Interferon Alfa (INN) Manufacturing Base Distribution, Product Types 3.4.1 Interferon Alfa (INN) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Interferon Alfa (INN) Product Type 3.4.3 Date of International Manufacturers Enter into Interferon Alfa (INN) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Interferon Alfa (INN) Market Size by Type (2016-2021) 4.1.1 Global Interferon Alfa (INN) Sales by Type (2016-2021) 4.1.2 Global Interferon Alfa (INN) Revenue by Type (2016-2021) 4.1.3 Interferon Alfa (INN) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Interferon Alfa (INN) Market Size Forecast by Type (2022-2027) 4.2.1 Global Interferon Alfa (INN) Sales Forecast by Type (2022-2027) 4.2.2 Global Interferon Alfa (INN) Revenue Forecast by Type (2022-2027) 4.2.3 Interferon Alfa (INN) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Interferon Alfa (INN) Market Size by Application (2016-2021) 5.1.1 Global Interferon Alfa (INN) Sales by Application (2016-2021) 5.1.2 Global Interferon Alfa (INN) Revenue by Application (2016-2021) 5.1.3 Interferon Alfa (INN) Price by Application (2016-2021) 5.2 Interferon Alfa (INN) Market Size Forecast by Application (2022-2027) 5.2.1 Global Interferon Alfa (INN) Sales Forecast by Application (2022-2027) 5.2.2 Global Interferon Alfa (INN) Revenue Forecast by Application (2022-2027) 5.2.3 Global Interferon Alfa (INN) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Interferon Alfa (INN) Market Size YoY Growth 2016-2027 6.1.1 Japan Interferon Alfa (INN) Sales YoY Growth 2016-2027 6.1.2 Japan Interferon Alfa (INN) Revenue YoY Growth 2016-2027 6.1.3 Japan Interferon Alfa (INN) Market Share in Global Market 2016-2027 6.2 Japan Interferon Alfa (INN) Market Size by Players (International and Local Players) 6.2.1 Japan Top Interferon Alfa (INN) Players by Sales (2016-2021) 6.2.2 Japan Top Interferon Alfa (INN) Players by Revenue (2016-2021) 6.3 Japan Interferon Alfa (INN) Historic Market Review by Type (2016-2021) 6.3.1 Japan Interferon Alfa (INN) Sales Market Share by Type (2016-2021) 6.3.2 Japan Interferon Alfa (INN) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Interferon Alfa (INN) Price by Type (2016-2021) 6.4 Japan Interferon Alfa (INN) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Interferon Alfa (INN) Sales Forecast by Type (2022-2027) 6.4.2 Japan Interferon Alfa (INN) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Interferon Alfa (INN) Price Forecast by Type (2022-2027) 6.5 Japan Interferon Alfa (INN) Historic Market Review by Application (2016-2021) 6.5.1 Japan Interferon Alfa (INN) Sales Market Share by Application (2016-2021) 6.5.2 Japan Interferon Alfa (INN) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Interferon Alfa (INN) Price by Application (2016-2021) 6.6 Japan Interferon Alfa (INN) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Interferon Alfa (INN) Sales Forecast by Application (2022-2027) 6.6.2 Japan Interferon Alfa (INN) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Interferon Alfa (INN) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Interferon Alfa (INN) Market Size YoY Growth 2016-2027 7.2 North America Interferon Alfa (INN) Market Facts & Figures by Country 7.2.1 North America Interferon Alfa (INN) Sales by Country (2016-2021) 7.2.2 North America Interferon Alfa (INN) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Interferon Alfa (INN) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Interferon Alfa (INN) Market Facts & Figures by Region 8.2.1 Asia Pacific Interferon Alfa (INN) Sales by Region (2016-2021) 8.2.2 Asia Pacific Interferon Alfa (INN) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Interferon Alfa (INN) Market Size YoY Growth 2016-2027 9.2 Europe Interferon Alfa (INN) Market Facts & Figures by Country 9.2.1 Europe Interferon Alfa (INN) Sales by Country (2016-2021) 9.2.2 Europe Interferon Alfa (INN) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Interferon Alfa (INN) Market Size YoY Growth 2016-2027 10.2 Latin America Interferon Alfa (INN) Market Facts & Figures by Country 10.2.1 Latin America Interferon Alfa (INN) Sales by Country (2016-2021) 10.2.2 Latin America Interferon Alfa (INN) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Interferon Alfa (INN) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Interferon Alfa (INN) Market Facts & Figures by Country 11.2.1 Middle East and Africa Interferon Alfa (INN) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Interferon Alfa (INN) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Description and Business Overview 12.1.3 Roche Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Interferon Alfa (INN) Products Offered 12.1.5 Roche Recent Development 12.2 Anke Biotechnology 12.2.1 Anke Biotechnology Corporation Information 12.2.2 Anke Biotechnology Description and Business Overview 12.2.3 Anke Biotechnology Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Anke Biotechnology Interferon Alfa (INN) Products Offered 12.2.5 Anke Biotechnology Recent Development 12.3 Bayer 12.3.1 Bayer Corporation Information 12.3.2 Bayer Description and Business Overview 12.3.3 Bayer Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bayer Interferon Alfa (INN) Products Offered 12.3.5 Bayer Recent Development 12.4 Merck & Co 12.4.1 Merck & Co Corporation Information 12.4.2 Merck & Co Description and Business Overview 12.4.3 Merck & Co Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Merck & Co Interferon Alfa (INN) Products Offered 12.4.5 Merck & Co Recent Development 12.5 Tri-Prime 12.5.1 Tri-Prime Corporation Information 12.5.2 Tri-Prime Description and Business Overview 12.5.3 Tri-Prime Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Tri-Prime Interferon Alfa (INN) Products Offered 12.5.5 Tri-Prime Recent Development 12.6 Kawin 12.6.1 Kawin Corporation Information 12.6.2 Kawin Description and Business Overview 12.6.3 Kawin Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Kawin Interferon Alfa (INN) Products Offered 12.6.5 Kawin Recent Development 12.7 Genzon Pharma 12.7.1 Genzon Pharma Corporation Information 12.7.2 Genzon Pharma Description and Business Overview 12.7.3 Genzon Pharma Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Genzon Pharma Interferon Alfa (INN) Products Offered 12.7.5 Genzon Pharma Recent Development 12.8 Novartis 12.8.1 Novartis Corporation Information 12.8.2 Novartis Description and Business Overview 12.8.3 Novartis Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Novartis Interferon Alfa (INN) Products Offered 12.8.5 Novartis Recent Development 12.9 Biogen 12.9.1 Biogen Corporation Information 12.9.2 Biogen Description and Business Overview 12.9.3 Biogen Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Biogen Interferon Alfa (INN) Products Offered 12.9.5 Biogen Recent Development 12.10 Merck KGaA 12.10.1 Merck KGaA Corporation Information 12.10.2 Merck KGaA Description and Business Overview 12.10.3 Merck KGaA Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Merck KGaA Interferon Alfa (INN) Products Offered 12.10.5 Merck KGaA Recent Development 12.11 Roche 12.11.1 Roche Corporation Information 12.11.2 Roche Description and Business Overview 12.11.3 Roche Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Roche Interferon Alfa (INN) Products Offered 12.11.5 Roche Recent Development 12.12 Huaxin Biotechnology 12.12.1 Huaxin Biotechnology Corporation Information 12.12.2 Huaxin Biotechnology Description and Business Overview 12.12.3 Huaxin Biotechnology Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Huaxin Biotechnology Products Offered 12.12.5 Huaxin Biotechnology Recent Development 12.13 Harbin Pharmaceutical 12.13.1 Harbin Pharmaceutical Corporation Information 12.13.2 Harbin Pharmaceutical Description and Business Overview 12.13.3 Harbin Pharmaceutical Interferon Alfa (INN) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Harbin Pharmaceutical Products Offered 12.13.5 Harbin Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Interferon Alfa (INN) Industry Trends 13.2 Interferon Alfa (INN) Market Drivers 13.3 Interferon Alfa (INN) Market Challenges 13.4 Interferon Alfa (INN) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Interferon Alfa (INN) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Interferon Alfa (INN) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Long-lasting Type Table 3. Major Manufacturers of Ordinary Type Table 4. Global Interferon Alfa (INN) Market Size Growth Rate by Application (2021-2027) & (K Doses) Table 5. Global Interferon Alfa (INN) Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Interferon Alfa (INN) Sales by Regions (2016-2021) & (K Doses) Table 7. Global Interferon Alfa (INN) Sales Market Share by Regions (2016-2021) Table 8. Global Interferon Alfa (INN) Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Interferon Alfa (INN) Sales Forecast by Region (2022-2027) & (K Doses) Table 10. Global Interferon Alfa (INN) Sales Market Share Forecast by Region (2022-2027) Table 11. Global Interferon Alfa (INN) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Interferon Alfa (INN) Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Interferon Alfa (INN) Sales by Manufacturers (2016-2021) (K Doses) Table 14. Global Interferon Alfa (INN) Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Interferon Alfa (INN) Manufacturers by Revenue (US$ Million) in 2020 Table 16. Interferon Alfa (INN) Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Interferon Alfa (INN) Revenue Share by Manufacturers (2016-2021) Table 18. Global Interferon Alfa (INN) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Interferon Alfa (INN) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Alfa (INN) as of 2020) Table 20. Key Manufacturers Interferon Alfa (INN) Price (2016-2021) (US$/Dose) Table 21. Interferon Alfa (INN) Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Interferon Alfa (INN) Product Type Table 23. Date of International Manufacturers Enter into Interferon Alfa (INN) Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Interferon Alfa (INN) Sales by Type (2016-2021) (K Doses) Table 26. Global Interferon Alfa (INN) Sales Share by Type (2016-2021) Table 27. Global Interferon Alfa (INN) Revenue by Type (2016-2021) (US$ Million) Table 28. Global Interferon Alfa (INN) Revenue Share by Type (2016-2021) Table 29. Interferon Alfa (INN) Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose) Table 30. Global Interferon Alfa (INN) Sales Forecast by Type (2022-2027) & (K Doses) Table 31. Global Interferon Alfa (INN) Sales Market Share Forecast by Type (2022-2027) Table 32. Global Interferon Alfa (INN) Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Interferon Alfa (INN) Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Interferon Alfa (INN) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose) Table 35. Global Interferon Alfa (INN) Sales by Application (2016-2021) (K Doses) Table 36. Global Interferon Alfa (INN) Sales Share by Application (2016-2021) Table 37. Global Interferon Alfa (INN) Revenue by Application (2016-2021) (US$ Million) Table 38. Global Interferon Alfa (INN) Revenue Share by Application (2016-2021) Table 39. Interferon Alfa (INN) Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose) Table 40. Global Interferon Alfa (INN) Sales Forecast by Application (2022-2027) & (K Doses) Table 41. Global Interferon Alfa (INN) Sales Market Share Forecast by Application (2022-2027) Table 42. Global Interferon Alfa (INN) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Interferon Alfa (INN) Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Interferon Alfa (INN) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose) Table 45. Japan Interferon Alfa (INN) Sales (K Doses) of Key Companies (2016-2021) Table 46. Japan Interferon Alfa (INN) Sales Share by Company (2016-2021) Table 47. Japan Interferon Alfa (INN) Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Interferon Alfa (INN) Revenue Share by Company (2016-2021) Table 49. Japan Interferon Alfa (INN) Sales (K Doses) by Type (2016-2021) Table 50. Japan Interferon Alfa (INN) Sales Share by Type (2016-2021) Table 51. Japan Interferon Alfa (INN) Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Interferon Alfa (INN) Price (US$/Dose) by Type (2016-2021) Table 53. Japan Interferon Alfa (INN) Sales (K Doses) by Type (2022-2027) Table 54. Japan Interferon Alfa (INN) Sales Share by Type (2022-2027) Table 55. Japan Interferon Alfa (INN) Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Interferon Alfa (INN) Revenue Share by Type (2022-2027) Table 57. Japan Interferon Alfa (INN) Price (US$/Dose) by Type (2022-2027) Table 58. Japan Interferon Alfa (INN) Sales (K Doses) by Application (2016-2021) Table 59. Japan Interferon Alfa (INN) Sales Share by Application (2016-2021) Table 60. Japan Interferon Alfa (INN) Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Interferon Alfa (INN) Price (US$/Dose) by Application (2016-2021) Table 62. Japan Interferon Alfa (INN) Sales (K Doses) by Application (2022-2027) Table 63. Japan Interferon Alfa (INN) Sales Share by Application (2022-2027) Table 64. Japan Interferon Alfa (INN) Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Interferon Alfa (INN) Revenue Share by Application (2022-2027) Table 66. Japan Interferon Alfa (INN) Price (US$/Dose) by Application (2022-2027) Table 67. North America Interferon Alfa (INN) Sales by Country (2016-2021) & (K Doses) Table 68. North America Interferon Alfa (INN) Sales Market Share by Country (2016-2021) Table 69. North America Interferon Alfa (INN) Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Interferon Alfa (INN) Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Interferon Alfa (INN) Sales by Region (2016-2021) & (K Doses) Table 72. Asia Pacific Interferon Alfa (INN) Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Interferon Alfa (INN) Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Interferon Alfa (INN) Revenue Market Share by Region (2016-2021) Table 75. Europe Interferon Alfa (INN) Sales by Country (2016-2021) & (K Doses) Table 76. Europe Interferon Alfa (INN) Sales Market Share by Country (2016-2021) Table 77. Europe Interferon Alfa (INN) Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Interferon Alfa (INN) Revenue Market Share by Country (2016-2021) Table 79. Latin America Interferon Alfa (INN) Sales by Country (2016-2021) & (K Doses) Table 80. Latin America Interferon Alfa (INN) Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Interferon Alfa (INN) Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Interferon Alfa (INN) Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Interferon Alfa (INN) Sales by Country (2016-2021) & (K Doses) Table 84. Middle East and Africa Interferon Alfa (INN) Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Interferon Alfa (INN) Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Interferon Alfa (INN) Revenue Market Share by Country (2016-2021) Table 87. Roche Corporation Information Table 88. Roche Description and Business Overview Table 89. Roche Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 90. Roche Interferon Alfa (INN) Product Table 91. Roche Recent Development Table 92. Anke Biotechnology Corporation Information Table 93. Anke Biotechnology Description and Business Overview Table 94. Anke Biotechnology Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 95. Anke Biotechnology Product Table 96. Anke Biotechnology Recent Development Table 97. Bayer Corporation Information Table 98. Bayer Description and Business Overview Table 99. Bayer Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 100. Bayer Product Table 101. Bayer Recent Development Table 102. Merck & Co Corporation Information Table 103. Merck & Co Description and Business Overview Table 104. Merck & Co Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 105. Merck & Co Product Table 106. Merck & Co Recent Development Table 107. Tri-Prime Corporation Information Table 108. Tri-Prime Description and Business Overview Table 109. Tri-Prime Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 110. Tri-Prime Product Table 111. Tri-Prime Recent Development Table 112. Kawin Corporation Information Table 113. Kawin Description and Business Overview Table 114. Kawin Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 115. Kawin Product Table 116. Kawin Recent Development Table 117. Genzon Pharma Corporation Information Table 118. Genzon Pharma Description and Business Overview Table 119. Genzon Pharma Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 120. Genzon Pharma Product Table 121. Genzon Pharma Recent Development Table 122. Novartis Corporation Information Table 123. Novartis Description and Business Overview Table 124. Novartis Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 125. Novartis Product Table 126. Novartis Recent Development Table 127. Biogen Corporation Information Table 128. Biogen Description and Business Overview Table 129. Biogen Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 130. Biogen Product Table 131. Biogen Recent Development Table 132. Merck KGaA Corporation Information Table 133. Merck KGaA Description and Business Overview Table 134. Merck KGaA Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 135. Merck KGaA Product Table 136. Merck KGaA Recent Development Table 137. Zydus Cadila Corporation Information Table 138. Zydus Cadila Description and Business Overview Table 139. Zydus Cadila Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 140. Zydus Cadila Product Table 141. Zydus Cadila Recent Development Table 142. Huaxin Biotechnology Corporation Information Table 143. Huaxin Biotechnology Description and Business Overview Table 144. Huaxin Biotechnology Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 145. Huaxin Biotechnology Product Table 146. Huaxin Biotechnology Recent Development Table 147. Harbin Pharmaceutical Corporation Information Table 148. Harbin Pharmaceutical Description and Business Overview Table 149. Harbin Pharmaceutical Interferon Alfa (INN) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 150. Harbin Pharmaceutical Product Table 151. Harbin Pharmaceutical Recent Development Table 152. Interferon Alfa (INN) Market Trends Table 153. Interferon Alfa (INN) Market Drivers Table 154. Interferon Alfa (INN) Market Challenges Table 155. Interferon Alfa (INN) Market Restraints Table 156. Interferon Alfa (INN) Customers List Table 157. Interferon Alfa (INN) Distributors List Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Interferon Alfa (INN) Product Picture Figure 2. Global Interferon Alfa (INN) Sales Market Share by Type in 2020 & 2027 Figure 3. Long-lasting Type Product Picture Figure 4. Ordinary Type Product Picture Figure 5. Global Interferon Alfa (INN) Sales Market Share by Application in 2020 & 2027 Figure 6. Hepatitis Figure 7. Multiple Sclerosis Figure 8. Others Figure 9. Interferon Alfa (INN) Report Years Considered Figure 10. Global Interferon Alfa (INN) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Interferon Alfa (INN) Market Size 2016-2027 (US$ Million) Figure 12. Global Interferon Alfa (INN) Sales 2016-2027 (K Doses) Figure 13. Global Interferon Alfa (INN) Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Interferon Alfa (INN) Sales Market Share by Region (2016-2021) Figure 15. Global Interferon Alfa (INN) Sales Market Share by Region in 2020 Figure 16. Global Interferon Alfa (INN) Revenue Market Share by Region (2016-2021) Figure 17. Global Interferon Alfa (INN) Revenue Market Share by Region in 2020 Figure 18. Global Interferon Alfa (INN) Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Interferon Alfa (INN) Revenue in 2020 Figure 20. Interferon Alfa (INN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Interferon Alfa (INN) Sales Market Share by Type (2016-2021) Figure 22. Global Interferon Alfa (INN) Sales Market Share by Type in 2020 Figure 23. Global Interferon Alfa (INN) Revenue Market Share by Type (2016-2021) Figure 24. Global Interferon Alfa (INN) Revenue Market Share by Type in 2020 Figure 25. Global Interferon Alfa (INN) Sales Market Share by Application (2016-2021) Figure 26. Global Interferon Alfa (INN) Sales Market Share by Application in 2020 Figure 27. Global Interferon Alfa (INN) Revenue Market Share by Application (2016-2021) Figure 28. Global Interferon Alfa (INN) Revenue Market Share by Application in 2020 Figure 29. Japan Interferon Alfa (INN) Sales Growth Rate 2016-2027 (K Doses) Figure 30. Japan Interferon Alfa (INN) Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. Japan Interferon Alfa (INN) Market Share in Global Market 2016-2027 Figure 32. Japan 5 and 10 Largest Interferon Alfa (INN) Players Market Share by Revenue in Interferon Alfa (INN) in 2020 Figure 33. Japan Interferon Alfa (INN) Revenue Share by Type (2016-2021) Figure 34. Japan Interferon Alfa (INN) Revenue Growth Rate by Type in 2016 & 2020 Figure 35. Japan Interferon Alfa (INN) Revenue Share by Application (2016-2021) Figure 36. Japan Interferon Alfa (INN) Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Interferon Alfa (INN) Sales Growth Rate 2016-2021 (K Doses) Figure 38. North America Interferon Alfa (INN) Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Interferon Alfa (INN) Sales Market Share by Country in 2020 Figure 40. North America Interferon Alfa (INN) Revenue Market Share by Country in 2020 Figure 41. U.S. Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 42. U.S. Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 44. Canada Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Interferon Alfa (INN) Sales Growth Rate 2016-2021 (K Doses) Figure 46. Europe Interferon Alfa (INN) Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Interferon Alfa (INN) Sales Market Share by Country in 2020 Figure 48. Europe Interferon Alfa (INN) Revenue Market Share by Country in 2020 Figure 49. Germany Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 50. Germany Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 52. France Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 54. U.K. Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 56. Italy Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 58. Russia Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Interferon Alfa (INN) Sales Growth Rate 2016-2021 (K Doses) Figure 60. Asia Pacific Interferon Alfa (INN) Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Interferon Alfa (INN) Sales Market Share by Region in 2020 Figure 62. Asia Pacific Interferon Alfa (INN) Revenue Market Share by Region in 2020 Figure 63. China Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 64. China Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 66. Japan Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 68. South Korea Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 70. India Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 72. Australia Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 74. Taiwan Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 76. Indonesia Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 78. Thailand Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 80. Malaysia Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 82. Philippines Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 84. Vietnam Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Interferon Alfa (INN) Sales Growth Rate 2016-2021 (K Doses) Figure 86. Latin America Interferon Alfa (INN) Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Interferon Alfa (INN) Sales Market Share by Country in 2020 Figure 88. Latin America Interferon Alfa (INN) Revenue Market Share by Country in 2020 Figure 89. Mexico Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 90. Mexico Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 92. Brazil Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 94. Argentina Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Interferon Alfa (INN) Sales Growth Rate 2016-2021 (K Doses) Figure 96. Middle East and Africa Interferon Alfa (INN) Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Interferon Alfa (INN) Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Interferon Alfa (INN) Revenue Market Share by Country in 2020 Figure 99. Turkey Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 100. Turkey Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 102. Saudi Arabia Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Interferon Alfa (INN) Sales Growth Rate (2016-2021) (K Doses) Figure 104. UAE Interferon Alfa (INN) Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Interferon Alfa (INN) Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Roche Anke Biotechnology Bayer Merck & Co Tri-Prime Kawin Genzon Pharma Novartis Biogen Merck KGaA Zydus Cadila Huaxin Biotechnology Harbin Pharmaceutical